Order Article Reprints

da Fonseca CAR, Prado VC, Paltian JJ, Kazmierczak JC, Schumacher RF, Sari MHM, Cordeiro LM, da Silva AF, Soares FAA, Oliboni RdS, et al. 4-(Phenylselanyl)-2H-chromen-2-one-Loaded Nanocapsule Suspension—A Promising Breakthrough in Pain Management: Comprehensive Molecular Docking, Formulation Design, and Toxicological and Pharmacological Assessments in Mice. Pharmaceutics. 2024; 16(2):269. https://doi.org/10.3390/pharmaceutics16020269

da Fonseca, Caren Aline Ramson, Vinicius Costa Prado, Jaini Janke Paltian, Jean Carlo Kazmierczak, Ricardo Frederico Schumacher, Marcel Henrique Marcondes Sari, Larissa Marafiga Cordeiro, Aline Franzen da Silva, Felix Alexandre Antunes Soares, Robson da Silva Oliboni, and et al. 2024. "4-(Phenylselanyl)-2H-chromen-2-one-Loaded Nanocapsule Suspension—A Promising Breakthrough in Pain Management: Comprehensive Molecular Docking, Formulation Design, and Toxicological and Pharmacological Assessments in Mice" Pharmaceutics 16, no. 2: 269. https://doi.org/10.3390/pharmaceutics16020269

da Fonseca, C. A. R., Prado, V. C., Paltian, J. J., Kazmierczak, J. C., Schumacher, R. F., Sari, M. H. M., Cordeiro, L. M., da Silva, A. F., Soares, F. A. A., Oliboni, R. d. S., Luchese, C., Cruz, L., & Wilhelm, E. A. (2024). 4-(Phenylselanyl)-2H-chromen-2-one-Loaded Nanocapsule Suspension—A Promising Breakthrough in Pain Management: Comprehensive Molecular Docking, Formulation Design, and Toxicological and Pharmacological Assessments in Mice. Pharmaceutics, 16(2), 269. https://doi.org/10.3390/pharmaceutics16020269